NDC 81607-018 – Liraglutide

Liraglutide 6 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC81607-018

Product details

Brand name
Liraglutide
Generic name
Liraglutide
Labeler
Orbicular Pharmaceutical Technologies Private Limited
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
ANDA · ANDA217590
Marketed since
January 21, 2026
Listing expires
December 31, 2027
Pharmacologic class
GLP-1 Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Liraglutide →

Package NDC codes (2)

Package NDCDescriptionSince
81607-018-013 SYRINGE, PLASTIC in 1 CARTON (81607-018-01) / 3 mL in 1 SYRINGE, PLASTICJan 21, 2026
81607-018-022 SYRINGE, PLASTIC in 1 CARTON (81607-018-02) / 3 mL in 1 SYRINGE, PLASTICJan 21, 2026

Other Liraglutide products